These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2319836)

  • 21. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme.
    Cheng MB; Wang JC; Li YH; Liu XY; Zhang X; Chen DW; Zhou SF; Zhang Q
    J Control Release; 2008 Jul; 129(1):41-8. PubMed ID: 18474405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The preparation and evaluation of a tablet dosage form of cyclosporine in dogs.
    Abdallah HY; Mayersohn M
    Pharm Res; 1991 Apr; 8(4):518-22. PubMed ID: 1871050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of incorporating cyclosporine into liposomes to reduce its nephrotoxicity.
    Smeesters C; Giroux L; Vinet B; Arnoux R; Chaland P; Corman J; St-Louis G; Daloze P
    Can J Surg; 1988 Jan; 31(1):34-6. PubMed ID: 3257403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic model of diltiazem.
    Kölle EU; Ochs HR; Vollmer KO
    Arzneimittelforschung; 1983; 33(7):972-7. PubMed ID: 6684932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular bioavailability of cyclosporine after oral administration.
    Tabbara KF; Gee SS; Alvarez H
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):656-9. PubMed ID: 3363663
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
    Grove M; Müllertz A; Nielsen JL; Pedersen GP
    Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine pharmacokinetics and pharmacodynamics after oral administration in the rat.
    Didlake RH; Kim EK; Grevel J; Jarolimek L; Kahan BD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):692-5. PubMed ID: 2966483
    [No Abstract]   [Full Text] [Related]  

  • 28. Microemulsions for improved peptide absorption from the gastrointestinal tract.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):205-20. PubMed ID: 2051845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
    Liu XL; Tang J; Song J; He J; Xu P; Peng WX
    Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of oral bioavailability of genistein and genistin in rats.
    Kwon SH; Kang MJ; Huh JS; Ha KW; Lee JR; Lee SK; Lee BS; Han IH; Lee MS; Lee MW; Lee J; Choi YW
    Int J Pharm; 2007 Jun; 337(1-2):148-54. PubMed ID: 17280808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats.
    Ryffel B; Donatsch P; Hiestand P; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S95-9. PubMed ID: 3458551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption kinetics of cyclosporine in healthy volunteers.
    Gupta SK; Benet LZ
    Biopharm Drug Dispos; 1989; 10(6):591-6. PubMed ID: 2611359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of seocalcitol III. Administration of lipid-based formulations to minipigs in the fasted and fed state.
    Grove M; Müllertz A; Pedersen GP; Nielsen JL
    Eur J Pharm Sci; 2007 May; 31(1):8-15. PubMed ID: 17383165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biopharmaceutic evaluation of furosemide as a potential candidate for a modified release peroral dosage form.
    Ritschel WA; Menon A; Sakr A
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):629-36. PubMed ID: 1787770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size.
    Tarr BD; Yalkowsky SH
    Pharm Res; 1989 Jan; 6(1):40-3. PubMed ID: 2717516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage.
    Wassef R; Cohen Z; Langer B
    Transplantation; 1985 Nov; 40(5):489-93. PubMed ID: 3877356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing the absorption of valspodar, a P-glycoprotein modulator, Part II: Quantifying its pharmacokinetic variability and refining the bioavailability estimate.
    Kovarik JM; Mueller EA; Richard F; Tetzloff W
    J Clin Pharmacol; 1997 Nov; 37(11):1009-14. PubMed ID: 9505993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetic study of brompiride in rats after its administration by intravenous, oral and intramuscular routes. II].
    Farré AJ; Canals R; Calderó JM
    Arch Farmacol Toxicol; 1978 Apr; 4(1):108-10. PubMed ID: 697373
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres.
    Yanagawa A; Iwayama T; Saotome T; Shoji Y; Takano K; Oka H; Nakagawa T; Mizushima Y
    J Microencapsul; 1989; 6(2):161-4. PubMed ID: 2723958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.
    Karlsson MO; Lindberg-Freijs A
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):293-311. PubMed ID: 2231321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.